- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Lilly, GE announce cancer diagnostic breakthrough
October 21, 2009
J.K. WallEli Lilly and Co. and General Electric Co. say they've made a breakthrough in cancer research that could help Lilly cut the
size and cost of its clinical trials.
MoreLilly reports $942 million profit in third quarter
October 21, 2009
J.K. WallExcluding special items, Eli Lilly and Co.'s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly's revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.
MoreMedco plans to compare Plavix, Effient in study
October 20, 2009
IBJ Staff and Associated PressMedco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with
Effient, a potential blockbuster drug sold by Indianapolis-based Eli Lilly and Co.
MoreCook calls for new approach to health reform
October 20, 2009
J.K. WallFounder of medical device firm says Congress should fund network of low-cost clinics.
MoreEndocyte receives $26M infusion from investors
October 16, 2009
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
MoreLilly to pay Idaho $13M in drug settlement
October 14, 2009
IBJ Staff and Associated PressIdaho is getting $13 million as part of a settlement reached with Indianapolis-based Eli Lilly and Co. over its marketing
of
anti-psychotic drug Zyprexa.
MoreLilly to sell Lafayette plant to German firm
October 14, 2009
J.K. WallNearly 700 workers will be offered severance, new jobs
MoreBaucus health reform bill would stick Indiana companies with fees
October 10, 2009
IBJ StaffThe health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.
MoreLilly settles Zyprexa suit with S. Carolina
October 7, 2009
IBJ StaffEli Lilly and Co. has agreed to settle the State of South Carolina's lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.
MoreLilly's win in Evista patent case crucial, analyst says
September 24, 2009
Scott OlsonA decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.'s Evista marks a major
victory for the company, says an analyst who closely follows the pharmaceutical industry.
MoreJudge upholds Lilly's Evista patent
September 24, 2009
J.K. WallA federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.’s drug Evista, the company announced
late yesterday.
MoreLilly agrees to settle more state Zyprexa suits
September 22, 2009
Eli Lilly and Co. has agreed to confidential terms to settle lawsuits brought by seven states alleging the company illegally
marketed bestselling antipsychotic drug Zyprexa, Bloomberg News reported today.
MoreMead Johnson plans expansion in Evansville
September 21, 2009
IBJ Staff and Associated PressMead Johnson Nutrition plans to spend nearly $33 million at a southwestern Indiana facility where it plans to start making
powdered infant formula products.
MoreUPDATE: Pipeline challenges force Lilly restructuring moves
September 14, 2009
J.K. WallSince John Lechleiter was named CEO 18 months ago, he's bet that Eli Lilly and Co. could face down its looming patent challenges
by launching innovative new medicines. Today's announcement of 5,500 job cuts by the end of 2011 and a restructuring of the
company's business units ups the ante on that bet, while indicating that it isn't working yet.
MoreLilly reorganization to cut 5,500 positions over 2 years
September 14, 2009
J.K. WallEli Lilly and Co. will cut 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses revenue
from its bestselling drug, Zyprexa. Lilly CEO John Lechleiter said he did not know how many of those cuts would occur in central
Indiana. But with
13,600 employees working in the Indianapolis area, he acknowledged the largest chunk of reductions likely would come here.
MoreStudy weakens Lilly's fight against price controls
September 12, 2009
IBJ StaffEli Lilly and Co. and its peers might be back in Congress’ sights as lawmakers hunt for more ways to cut health care
costs. A new study in the influential Health Affairs journal concludes that European drugmakers operating
in markets with pharmaceutical price controls have produced proportionally more innovations than their U.S. counterparts.
MoreMedical device developer receives $1M in federal funding
September 10, 2009
Scott OlsonIndianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
MoreLilly paid doctors to prescribe Zyprexa, notes say
September 8, 2009
IBJ StaffEli Lilly and Co. paid doctors in South Carolina for participating in a speakers' program in exchange for prescribing the
antipsychotic Zyprexa, according to notes by Lilly sales representatives reviewed by Bloomberg News.
MoreVenture firms recapitalize Advanced Physical Therapy LLC
August 29, 2009
IBJ StaffLocally based venture capital firms Cardinal Equity Partners and Centerfield Capital Partners have joined with Chicago-based
bank Harris NA to recapitalize the state’s largest independent physical therapy provider.
MoreAIT Laboratories leaps up Inc.'s list
August 24, 2009
IBJ StaffThe Indianapolis-based forensics, clinical and pharmaceutical testing firm now ranks 598, up from 1,466 a year ago. The list
is based on percentage of revenue growth.
MoreLilly pays $224,000 to area doctors
August 17, 2009
IBJ StaffIt’s no secret that Eli Lilly and Co. is the biggest private employer in the Indianapolis area. But
Lilly also supplemented the incomes of a few dozen local doctors — to the tune of more than $224,000 in just the first
quarter.
MoreDailyMed sales trim Arcadia losses
August 13, 2009
J.K. WallArcadia Resources Inc. narrowed its losses in its most recent quarter as it started to accelerate sales in its highly-touted
DailyMed program, the company said today.
MoreAbatement approval paves way for Covance jobs
August 12, 2009
Scott OlsonThe Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
MoreCook predicts blockbuster with new stent
August 12, 2009
J.K. WallBloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will
be a blockbuster.
MoreLilly software spinoff Maaguzi sells for $11 million
August 3, 2009
Chris O'MalleyInvestors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
See, I told u Indyman and Dipsicle....this 8 days is overkill. It's barely worth a weekend....great job Tony George! Your dream has been fulfilled....he fans want the I r l back. Thats how good it was.....and that sucked.
I have been in training for a short time now but right off I can see that safety and quality are the number one issues, my experience as of late has been a positive one, the employees along with Jeff the plant manager and the operation supervisor as well as the engineers are a highly motivated group of people, what an asset for the area to have and for company's in need of a quality metal products.
Pimlico
While I understand the severity of their actions as well as everyones eagerness to hold them responsible for thier lost funds, these gentlemen did know how to make money. Dispite thier poor decisions over the ownership of Fair they had made several wise investments which paid them greatly. This proves they do have the potential to rebuild so they can repay. I do not feel they should live the life of luxuary but given an opportunity could they find ways of repaying the debts? They are doing nothing now but being a burden on tax payers. Just a thought!!!!!
You guys have some "interesting" comments to say the least. I hope you will call in and share those opinions starting June 1. I'm looking forward to having you on the air.